Literature DB >> 24173774

The fate of Krüppel-like factor 9-positive hepatic carcinoma cells may be determined by the programmed cell death protein 5.

Da-Zhi Fu1, Ying Cheng, Hui He, Hai-Yang Liu, Yong-Feng Liu.   

Abstract

Liver cancer in men is the fifth most frequently diagnosed cancer worldwide. Human Krüppel-like factor (KLF9) gene, localized on human chromosome 9q13, has been implicated in mediating a diverse range of biological processes including stem cell maintenance and differentiation of T- and B-lymphocytes. In this study, we confirmed that the levels of KLF9 mRNA and protein were lower in hepatocellular carcinoma (HCC) tissue compared to normal tissue. In addition, we confirmed that upregulation of KLF9 inhibited cell proliferation and mobility and induce apoptosis in HepG2 cells depending on programmed cell death protein 5 (PDCD5) expression. However, no interaction was found between KLF9 and PDCD5 using fluorescence resonance energy transfer (FRET) and co-immunoprecipitation (co-IP). We confirmed that PDCD5 overexpression stimulated the promoter activities of KLF9 by luciferase reporter assays.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24173774     DOI: 10.3892/ijo.2013.2147

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  10 in total

1.  Immunomodulatory function of the active ingredients in traditional Chinese prescriptions on early stage esophageal cancer with dysplasia.

Authors:  Wenbo Jiang; Ning Qin; Tao Chen; Junwei Xu
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

Review 2.  Krüppel-like factors in hepatocellular carcinoma.

Authors:  Xiao-Jie Lu; Yan Shi; Jin-Lian Chen; Shijie Ma
Journal:  Tumour Biol       Date:  2015-02-06

3.  Fatty acid binding protein 5 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by degradation of Krüppel-like factor 9 mediated by miR-889-5p via cAMP-response element binding protein.

Authors:  Yanping Tang; Kezhi Li; Bangli Hu; Zhengmin Cai; Jilin Li; Hao Tao; Ji Cao
Journal:  Cancer Biol Ther       Date:  2022-12-31       Impact factor: 4.875

4.  Target and drug predictions for SARS-CoV-2 infection in hepatocellular carcinoma patients.

Authors:  Luhong Wang; Yinan Ding; Chuanyong Zhang; Rong Chen
Journal:  PLoS One       Date:  2022-05-31       Impact factor: 3.752

5.  The tumor promoting roles of HSP60 and HIF2α in gastric cancer cells.

Authors:  Wei-Wei Tong; Guang-Hui Tong; Hong Kong; Yong Liu
Journal:  Tumour Biol       Date:  2016-01-26

6.  Expression of Krüppel-like factor 9 in breast cancer patients and its effect on prognosis.

Authors:  Zirong Jiang; Zhiping Xu; Tinghui Hu; Bin Song; Feng Li; Kaiyin Wang
Journal:  Oncol Lett       Date:  2020-05-29       Impact factor: 2.967

7.  Krüppel-like Factor 9 (KLF9) Suppresses Hepatocellular Carcinoma (HCC)-Promoting Oxidative Stress and Inflammation in Mice Fed High-Fat Diet.

Authors:  Adam R Brown; Iad Alhallak; Rosalia C M Simmen; Stepan B Melnyk; Melissa E Heard-Lipsmeyer; Maria Theresa E Montales; Daniel Habenicht; Trang T Van; Frank A Simmen
Journal:  Cancers (Basel)       Date:  2022-03-29       Impact factor: 6.639

8.  Identification of methylation signatures associated with CAR T cell in B-cell acute lymphoblastic leukemia and non-hodgkin's lymphoma.

Authors:  Jiwei Song; FeiMing Huang; Lei Chen; KaiYan Feng; Fangfang Jian; Tao Huang; Yu-Dong Cai
Journal:  Front Oncol       Date:  2022-08-11       Impact factor: 5.738

9.  Progesterone receptor inhibits the proliferation and invasion of endometrial cancer cells by up regulating Krüppel-like factor 9.

Authors:  Xiaofang Yan; Huilin Zhang; Jieqi Ke; Yongli Zhang; Chenyun Dai; Mei Zhu; Feizhou Jiang; Hongdi Zhu; Ling Zhang; Xin Zuo; Weiling Li; Xiufeng Yin; Xiaoping Wan
Journal:  Transl Cancer Res       Date:  2020-04       Impact factor: 1.241

10.  Upregulation of microRNA miR-652-3p is a prognostic risk factor for hepatocellular carcinoma and regulates cell proliferation, migration, and invasion.

Authors:  Xiaobin Chi; Yi Jiang; Yongbiao Chen; Lizhi Lv; Jianwei Chen; Fang Yang; Xiaojin Zhang; Fan Pan; Qiucheng Cai
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.